Alnylam Pharmaceuticals, Inc.
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene

Abstract:

The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a Serum Amyloid A (SAA) gene, and methods of using the dsRNA to inhibit expression of SAA